The Parkinson's disease market

Nature Reviews Drug Discovery

Volumn 10, Issue 8, 2011, Pages 571-572

  Huynh, Trung ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; CARBIDOPA PLUS LEVODOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CERE 120; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FIPAMEZOLE; GENE THERAPY AGENT; GLUTAMATE DECARBOXYLASE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; IPX 066; ISTRADEFYLLINE; KW 6500; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; NEURTURIN; NEW 1015; NLX P101; PARDOPRUNOX; PARVOVIRUS VECTOR; PRAMIPEXOLE; PRELADENANT; PROSAVIN; RASAGILINE; ROPINIROLE; SAFINAMIDE; SELEGILINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; CELL THERAPY; CONTROLLED RELEASE FORMULATION; DOPAMINE BRAIN LEVEL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DYSKINESIA; ECONOMIC ASPECT; FALLING; GENE MUTATION; HUMAN; MOTOR DYSFUNCTION; MOTOR FLUCTUATION; PARKINSON DISEASE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SIDE EFFECT; VIRAL GENE THERAPY;

ANTIPARKINSON AGENTS; DRUG DISCOVERY; HUMANS; LEVODOPA; PARKINSON DISEASE;

EID: 79960979236     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3515     Document Type: Article

References (3)

1. Datamonitor. Epidemiology: Parkinson's Disease-the aging population will cause the prevalence of Parkinson's disease to continue to grow. HC00039-001 (2011).
2. Olanow, C. W., Watts, R. L. & Koller W. C. (2001). An algorithm (decision tree) for the management of Parkinson's disease. Neurology, 56 (Suppl. 5), 1-88 (2011).
3. Olanow, C. W. et al. A double-blind delayed-start trial of rasagiline in Parkinson's disease. N. Engl. J. Med. 361, 1268-1278 (2009).